Cisplatin + RT for Triple Negative Breast Cancer
NCT01674842
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
RADIATION:
Radiation Therapy
DRUG:
Cisplatin
Sponsor
Dana-Farber Cancer Institute